Studies Find Natural Treatments for

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
164
Studies Find Natural Treatments for Coronavirus

https://www.greenmedinfo.com/blog/studies-fin...oronavirus

Contrary to what mass mainstream media would have you assume, coronaviruses aren't uncharted territory. In fact, human coronaviruses are responsible for 15-30% of common colds each year (1). More severe cases of coronavirus infections were observed during outbreaks of severe acute respiratory syndrome (SARS) and Middle Eastern respiratory syndrome (MERS), two coronavirus infections that led to pneumonia in some individuals who were infected.

These outbreaks sparked interest from the complementary medicine community who began investigating natural solutions for treating SARS and MERS infections, the studies of which have been compiled in our comprehensive database on Coronavirus Infection and Coronavirus Disease.

These natural substances demonstrating viral inhibition of SARS-coronavirus are likely also effective against the 2019 coronavirus, considering the two are closely related and share the same angiotensin-converting enzyme II-mediated infection (2). In other words, SARS-coronavirus and the 2019 novel coronavirus are both structurally and mechanistically similar and can be targeted by the same substances.

In fact, one paper published in the Chinese Journal of Preventive Medicine states that the 2019 novel coronavirus is actually less pathogenic than the SARS-coronavirus (2), suggesting that these natural substances may be even more effective in their coronavirus-inhibiting properties.

These naturally-occurring, whole food-derived substances with proven coronavirus-inhibiting properties are discussed below:

Licorice root. Glycyrrhizin, an active constituent of licorice roots, has been shown to exhibit potent inhibitory activity against SARS-coronavirus replication (3). Additionally, glycyrrhizin appears to be more effective during the early stages of coronavirus replication (3).
Flavonoids. The activity of coronavirus proteases is a key factor in coronaviruses' ability to propagate in cells. Flavonoids, however, directly inhibit coronavirus protease activity, resulting in decreased virus propagation (4). The flavonoids with the highest virus inhibitory power appear to be herbacetin, isobavachalcone, quercetin 3‐β‐d‐glucoside, and helichrysetin.
Chameleon plant (Houttuynia cordata). In one animal study, Chameleon plant aqueous extract demonstrated significant antiviral activity against the SARS-coronavirus in vivo (5). The study also found that the herb stimulated the proliferation of mouse splenic lymphocytes in a dose-dependent manner, suggesting it also functions as an immunomodulatory plant (5).
Chinese medicine preparations. Chinese medicine has been frequently used as an adjunct therapy to treat SARS patients, as evidenced by a Cochrane systematic review that concluded Chinese Medicine as an adjunct therapy "may improve symptoms, quality of life and absorption of pulmonary infiltration, and decrease the corticosteroid dosage for SARS patients" (6). Another study has also proposed ShuFengJieDu Capsules and Lianhuaqingwen Capsule as a potentially effective treatment for 2019 novel coronavirus, considering previous studies demonstrating their ability to both treat and prevent respiratory infectious viruses (7).
Related article on Greenmedinfo.com:

Can Herbal Medicines Fight Wuhan Coronavirus?

Licorice Shown to Kill SARS and Other Lethal Viruses

The Proof is in the Panic: We Need a New Strategy against Viral Infections

Natural Treatments for Ebola Virus Exist, Research Suggests
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CreditRefresh's AI Tackles 1,000+ Disputes Launch Month

Updated Category News Views 3

AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...

Continue Reading
Inturai Ventures Closes Final Tranche with a Twist

Updated Category News Views 2

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...

Continue Reading
Hims & Hers Faces Lawsuit as FTC Alleges Privacy Breach

Updated Category News Views 2

FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 2

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Amwell Revolutionizes Digital Care Platforms in 2026

Updated Category News Views 2

Amwell's Bold Move in Virtual Care Funny how in today’s digital age, where everyone is glued to their screens, healthcare can still feel like trying to piece together a jigsaw puzzle with missing pieces. But Amwell seems to have cracked the code, redefining digital care delivery like few others. Just recently, they bagged Frost & Sullivan's 2026 United States Technology...

Continue Reading
Reolink Unveils OMVI 2i Ultra at IFA 2026

Updated Category News Views 6

Reolink's Bold Move Into the Future of Home Security Amidst the hustle of Berlin's IFA 2026, Reolink dropped its latest gem: the OMVI 2i Ultra—an all-in-one security powerhouse promising to change the game for home protection junkies. As usual, Reolink's got its eyes on the prize, pushing boundaries with this latest lineup. OMVI 2i Ultra: Dual-View Revolution If you've...

Continue Reading
Bamboo Unveils Tailored Home Insurance for Texans

Updated Category News Views 2

Adapt or Get Left Behind: The Texas Insurance Scene In a world where costs are ballooning and the pressure on the wallet grows heavier, here comes Bamboo Insurance swinging into Texas like a hopeful knight. This plucky insurer is rolling out the Texas Essential Homeowner Program, a highly adaptable, admitted policy that promises to put some power back into the hands of...

Continue Reading
Chris Auffenberg Buick: 1.9% APR Drives New Deals

Updated Category News Views 3

New Financing Options in Carbondale In a world where financing a car sometimes feels like predicting the weather—unreliable and erratic—Chris Auffenberg Buick is turning the tables down in Carbondale with a refreshing approach. They're trotting out a 1.9% APR financing option for those Buick lovers who qualify, all through GM Financial. It's the kind of deal that...

Continue Reading
UGREEN's MagFlow Series: A Game-Changer in Charging

Updated Category News Views 2

UGREEN Unveils a Cool Revolution in Charging Out in Foxborough, UGREEN is shaking things up at its Smart Living Launch Event. The big reveal? The MagFlow Series, their flagship wireless charging lineup, which promises faster and cooler charging than ever before. UGREEN's taking wireless charging to new heights, and that's got my attention. What Makes MagFlow Stand Out...

Continue Reading
Labcorp Faces Lawsuit: Wiretapping Accusations Surface

Updated Category News Views 1

Labcorp's Legal Tangle Unveiled One minute you're on Labcorp's website searching for medical info, the next you're caught up in a class-action legal whirlwind. Legal drama is not on any patient’s checklist, but here we are, with Labcorp knee-deep in some serious allegations. The crux of the matter points to alleged wiretapping violations, with claims that Labcorp,...

Continue Reading

Top 5 Most Recently Viewed Articles

Simmons First National Stock Surges to New Heights at $23.75

Updated Category News Views 81

Simmons First National Stock Reaches New Highs Simmons First National Corporation (SFNC) recently achieved a commendable 52-week high, trading at $23.75. This milestone reflects a remarkable 64.74% increase over the past year, indicating robust investor confidence in the bank holding company's performance. The significant uptick in stock price illustrates the strong...

Continue Reading
Asembia Launches Groundbreaking Digital Retail Network for Patients

Updated Category News Views 337

Asembia Unveils the ASPN Digital Retail Network™ Asembia is excited to introduce the ASPN Digital Retail Network™, a revolutionary network designed to improve patient access to prescriptions. This expansive network brings together various pharmacy types, including retail, digital, and independent pharmacies, pushing the boundaries of how prescriptions are processed....

Continue Reading
Insights into Comfort Systems USA's Rising Short Interest Trends

Updated Category News Views 86

Examining the Surge in Short Interest for Comfort Systems USA Comfort Systems USA (NYSE: FIX) has seen a significant jump in its short interest, with a rise of 5.63% since the last report. The company has now revealed that about 553 thousand shares are being sold short, which accounts for roughly 2.25% of all available shares for trading. This increase suggests a...

Continue Reading
US Cleaning Services Market Growth Driven by Multifamily Homes

Updated Category News Views 143

Exploring the Growth of the US Cleaning Services Market The commercial and residential cleaning services market in the US is on the brink of significant growth. It's projected to increase by USD 36.81 billion in the coming years, fueled by the rising popularity of multifamily dwellings. As we delve deeper, we’ll explore what factors are propelling this expansion and...

Continue Reading
Invesco High Income Trust II and Senior Income Trust Announce Dividends

Updated Category News Views 125

Invesco High Income Trust II and Senior Income Trust Announce Dividends The Boards of Trustees for both Invesco High Income Trust II and Invesco Senior Income Trust have recently declared important dividends, marking a significant event for investors in these funds. Details of the Dividend Declaration The Funds have revealed critical dividend dates: the ex-date and record...

Continue Reading